Scholars Central

Conference abstractPublished 23 Oct 2017

Evaluation of six antifungal drugs against Candida glabrata isolates as an emerging pathogen for health care

Authors: Nasrin Amirrajab, Tahereh Shokohi, Hamid Badali, Mojtaba Didehdar, Mohammad Hosein Afsarian, Rasoul Mohammadi, Nazanin Lotfi

Health Ahvaz Jundishapur University of Medical Sciences, Iran Mazandaran University of Medical Sciences, Iran Arak University of Medical Sciences, Iran Fasa University of Medical Sciences, Iran Isfahan University of Medical Sciences, Iran

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Candida glabrata is a pathogenic yeast with several unique biological features and associated with an increased incidence rate of candidiasis. It exhibits a great degree of variation in its pathogenicity and antifungal susceptibility. Objectives: The aim of the present study was to evaluate the in vitro antifungal susceptibilities of the following six antifungal drugs against clinical C. glabrata strains: amphotericin B (Am B), ketoconazole (KTZ), fluconazole (FCZ), itraconazole (ITZ), voriconazole (VCZ), and caspofungin (CASP). Materials and Methods: Forty clinical C. glabrata strains were investigated using DNA sequencing. The in vitro antifungal susceptibility was determined as described in clinical laboratory standard institute (CLSI) documents (M27-A3 and M27-S4). Results: The sequence analysis of the isolate confirmed as C. glabrata and deposited on NCBI Gen Bank under the accession number no. KT763084-KT763123. The geometric mean MICs against all the tested strains were as follows, in increasing order: CASP (0.17 g/ mL), VCZ (0.67 g/mL), Am B (1.1 g/mL), ITZ (1.82 g/mL), KTZ (1.85 g/mL), and FCZ (6.7 g/mL). The resistance rates of the isolates to CASP, FCZ, ITZ, VZ, KTZ, and Am B were 5%, 10%, 72.5%, 37.5%, 47.5%, and 27.5%, respectively. Conclusions: These findings confirm that CASP, compared to the other antifungals, is the potent agent for treating candidiasis caused by C. glabrata. However, the clinical efficacy of these novel antifungals remains to be determined.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Advanced Practices in Nursing.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Advanced Practices in Nursing
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “Nasrin Amirrajab”
  • BylineArticles whose byline prints “Tahereh Shokohi”
  • BylineArticles whose byline prints “Hamid Badali”
  • BylineArticles whose byline prints “Mojtaba Didehdar”
  • BylineArticles whose byline prints “Mohammad Hosein Afsarian”
  • BylineArticles whose byline prints “Rasoul Mohammadi”
  • BylineArticles whose byline prints “Nazanin Lotfi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels